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The case of ‘protective fever and
chest signs’:
towards a better understanding
of general practice databases
General practice databases provide
researchers with information about the
realities of primary care. Empirical data of
GPs’ care of patients is a key resource in
primary care research,1 and it is a positive
sign that this trend is increasing in the
worldwide health science community. In a
number of countries, robust general
practice databases are emerging which
serve as an infrastructure for studies of
diagnosis, prognosis, and management of
health problems. An inherent strength of
the databases are their strong links to the
community in which the GPs practice and,
as a consequence, they enable direct
research of important health problems.2
Although GP databases are relevant to
large sectors of the science and
healthcare communities, they can be
difficult to interpret.
This month’s edition of the BJGP
presents five studies on diagnostic acuity
of serious (respiratory tract) infections in
the general practice population (Hay et al3,
Van den Bruel et al,4 Holm et al,5,6 and van
Duijn et al7). The studies examining
different populations report a generally low
a priori probability of serious disease —
well below 1%. All studies analyse
infectious signs and symptoms, while the
value of additional testing of inflammatory
markers is reported by Holm et al, for C-
reactive protein and procalcitonin.5,6 A
general finding was that signs, symptoms,
and additional testing were related to
diagnostic outcome. However,
construction of a robust algorithm was
only possible for ruling out serious
disease, not for identifying it.
A problem with ruling out rather than
diagnosing serious disease is that signs
and symptoms seldom enter the surgery in
their own right: patients’ beliefs and
expectations interact in their presentation
of illness, and determine as van Duijn et
al,7 report, diagnostic and therapeutic
outcome. Additionally, GPs not only
observe but also interpret while observing.
Van den Bruel et al,4 conclude that a GP’s
inference that ‘something is wrong’ is the
best predictor of serious disease.
The data from these studies are based
on the rich and detailed information8
derived from general practice databases.
However, some problems of interpretation
are apparent, and it is interesting to review
the findings of these studies in this
context.
The study of Hay et al,3 illustrates a
methodological approach to cope with
these problems in an elegant way. Their
study investigated diagnostic evidence by
predicting complicated courses of cough
in preschool children from observed
‘fever’ and ‘chest signs’. The
methodology to generate state-of-the-art
diagnostic evidence is still under
development,9 despite the fact that
making a timely diagnosis is the most
important clinical intervention to pursue in
general practice. Hay et al, apply a two-
step method in which they identify
predicting signs and symptoms in an
initial study (the ‘derivation study’),10
followed by validation of these findings in
a different population. This
methodological approach highlights the
need for research access to a rich
variation of general practice cohorts and
databases, and emphasises their
importance as a research infrastructure.
Access to different databases is enhanced
by standardisation of data recording.
Therefore, an internationally-recognised
classification of primary care should be
used when recording core data.11 Signs
and symptoms identified during diagnosis
are seldom independent from each other,
and the nature of their interactions is often
poorly understood. This is also the case
with infectious signs and symptoms. Van
den Bruel et al,4 identified up to five
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factors to predict severe infection. GPs’
inference that ‘something is wrong’, which
is a composite of observations, is difficult
to replicate. All findings presented in these
five articles are likely to benefit from
validation in similar general practice
populations elsewhere.
The main strength of these studies is in
refuting severe, life-threatening disease.
The studies of Holm et al,5,6 demonstrate
that this is not just due to subjectivity-
prone signs and symptoms. C-reactive
protein and procalcitonin have proven
their value as markers of inflammation in
selected, hospitalised patients but did not
add to diagnosis in general practice. The
main problem was that few patients had
truly elevated values of these inflammation
markers.
The low rate of abnormal levels of these
inflammation markers presents problems
in positively identifying severe or rare
cases in general practice. Calculating
probabilities of common symptoms for
relevant diseases requires large datasets,12
much larger than the numbers in these five
smaller studies. It is important to refute
spurious relationships and highlight
uncommon, severe morbidity. Linking
databases and pooling data in the
foreseeable future is likely to become a
necessity for general practice research.
This linking should not be limited to
national boarders.
Development of diagnostic strategies to
confirm major disease should be
encouraged, incorporating diagnosis of
rare, severe disease. Excluding the
probability of serious illness and disease is
a core part of general practice which can
benefit from research evidence. Studies
that help practitioners to exclude serious
illness and disease should not be ruled out
by editors, reviewers, funding bodies, and
the science community, as they are an
important part of research.
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Diagnosis is often regarded as the most
important aspect of clinical reasoning.
Most guidelines for medical performance
focus on improving practitioner’s
diagnostic accuracy. Standardisation of
diagnosis, based on unequivocal criteria13
that can be applied in various settings are
needed. However, the study of Hay et al,3
suggests that GPs are directing their
interventions at prognosis, rather than
diagnosis, of respiratory infection.
Prognostication and its research are
different from studies of the diagnostic
process in that observation over time and
patient’s medical life history are required,
in addition to the time-course of a single
episode.
Van Duijn et al,7 found that patients’
health beliefs were strong predictors of
antibiotic prescribing, and were found to
be more decisive than physical signs and
symptoms. The possibility of tracking
patients’ medical histories over time using
general practice databases is overlooked
by primary care and undervalued by the
science community. It would have been
difficult to conduct studies like that of Hay
et al, outside general practice.
Despite these positive aspects of the
research, the results of Hay et al, are, at
face value, a little puzzling. In their
derivation study they identify a number of
factors that were related to a complicated
course of illness, notably fever and chest
signs. However, in their validation study
neither is related to complicated outcome
of respiratory tract infection. Particularly
difficult to interpret is that in this part of
their study ‘fever’ and ‘chest signs’ appear
to be protective against adverse outcome
of respiratory tract infection. Factors
related to a certain outcome in one study
cannot be confirmed in another, which is
why the researchers applied a two-step
derivation–validation study design.
However, a shift from a ‘risk’ for
complications in the initial study to a
‘protective’ factor in the second one is an
entirely different story. This would suggest
the inclusion of spurious variables for
adverse outcome in the study design, or
recruitment of highly-selected patients or
practices. The comprehensive general
practice databases makes the finding of
‘spurious’ relations a realistic one.
Indiscriminate inclusion of patient and
practice characteristics in derivation
studies may turn this strength into a
weakness, as the likelihood of statistical
significance would present a researchers’
lottery with only jackpot. But uncritical
selection of prognostic factors would be
about the last criticism to make of the
study by Hay et al.3
‘Fever’ and ‘chest signs’ were more than
just significant factors in the derivation
study. These factors are likely to be linked
to ‘infection’ and, logically, the higher the
fever, or the stronger the indications of
involvement of the usually sterile lower
airways, the more severe the infection. The
validation study dismantled this common
sense as too simplistic, but that makes it
still hard to accept these factors as a
protective of adverse out come of
respiratory tract infections in young
children. Recruitment of highly-selective
patients and practices is also unlikely. The
participating practices in both studies
represent, beyond reasonable doubt,
regular primary care patient populations.
No important exclusions were imposed on
patient recruitment for the studies.
A possible explanation for the apparent
anomaly in the Hay et al, study could be
‘diagnostic shift’. The ultimate purpose of
the study was to identify criteria for
antibiotic prescribing in respiratory tract
infections; the complicated course of the
infection was to be the marker of that. GPs
are highly aware of the discrepancies in
their prescription of antibiotics. A
diagnostic shift could have occurred in
relation to children with symptoms of a
respiratory infection and additional
markers of complicated infection
including, but not exclusively, fever and
chest signs. With these children labelled
under another diagnosis — and excluded
from the study — ‘fever’ in the children
remaining in the validation study would
have lost its prognostic meaning. An
alternative explanation for the anomaly
could have been that routine treatment of
respiratory infections with antibiotics
prevented the development of
complications. The same mechanisms
may have affected the other studies
reviewed here.
Such a course of events is conceivable,
but it is uncertain whether this applies to
the study by Hay et al. It should signal,
though, that clinical processes and
decisions influence general practice data
with, at face value, unpredictable research
effects. The simple knee-jerk reaction
would be to refute practice-derived
databases for research purposes. An
alternative approach would be to invest in
the critical appraisal of research that is
based on general practice databases to
improve understanding of, among others,
diagnostic shifts.
The general practice research
community has been apologetic and
defensive towards one of the pearls of
clinical research: longitudinal patient-
centred databases of information
collected under regular general practice
care. A more pro-active approach is
required. Raising the profile of general
practice research should include
presenting the values of general practice
databases. General practice data are far
from ‘simple’ data ready for scientific
processing. The role of general practice
researchers is to provide guidance and in-
depth understanding for other scientists
so that they can make use of general
practice databases for clinical research.
This starts with gaining and sharing this in-
depth understanding ourselves. The
intriguing case of ‘protective fever and
chest signs’ is as good a starting point for
this as it can get.
Chris van Weel
Professor of General Practice, Radboud
University Nijmegen Medical Centre, the
Netherlands
REFERENCES
1. Van Weel C, Rosser WW. Improving health care
globally: a critical review of the necessity of family
medicine research and recommendations to build
research capacity. Ann Fam Med 2004; 2(Suppl 2):
S5–S16.
2. Nutting PA, Beasley JW, Werner JJ. Practice-based
research answer primary care questions. JAMA 1999;
281(8): 686–688.
3. Hay AD, Gorst C, Montgomery A, et al. Validation
of a clinical rule to predict complications of
acute cough in preschool children: a prospective
study in primary care. Br J Gen Pract 2007; 57(540):
530–537.
4. Van den Bruel A, Aertgeerts B, Bruyninckx R, et al.
Signs and symptoms for diagnosis of serious
infections in children: a prospective study in primary
care. Br J Gen Pract 2007; 57(540): 538–546.
5. Holm A, Nexoe J, Bistrup LA, et al. Aetiology and
prediction of pneumonia in lower respiratory tract
infection in primary care. Br J Gen Pract 2007;
57(540): 547–554.
6. Holm A, Pederson SS, Nexoe J, et al. Procalcitonin
versus C-reactive protein in predicting pneumonia in
Editorials
adults with lower respiratory tract infection. Br J
Gen Pract 2007; 57(540): 555–560.
7. Van Duijn HJ, Kuyvenhoven MM, Schellevis FG,
Verheij TJM. Illness behaviour and antibiotic
prescription in patients with respiratory tract
symptoms. Br J Gen Pract 2007; 57(540): 561–568.
8. Herbert CP. Future of research in family medicine:
where to from here? Ann Fam Med 2004; 2(Suppl 2):
S60–S64.
9. Knottnerus JA (ed.). The evidence base of clinical
diagnosis. London: BMJ Books, 2002.
10. Hay AD, Fahey T, Peters TJ, Wilson AD. Predicting
complications from acute cough in pre-school
children in primary care: a prospective cohort study.
Br J Gen Pract 2004; 54(498): 9–14.
11. World Organization of Family Doctors. ICPC-2:
International Classification of Primary Care. 2nd edn.
Oxford: Oxford University Press, 1998.
12. Okkes IM, Oskam SK, Lamberts H. The probability
of specific diagnoses for patients presenting with
common symptoms to Dutch family physicians.
J Fam Pract 2002; 51(1): 31–36.
13. Anonymous. ICHPPC-2 defined. Inclusion criteria
for the use of the rubrics of the International
Classification of Health Problems in Primary Care.
Oxford: Oxford University Press, 1983.
British Journal of General Practice, July 2007 525
Chris van Weel
Professor of General Practice,
Department of General Practice,
Radboud University Nijmegen Medical
Centre, 117-HAG, PO BOX 9101,
6500 HB Nijmegen, the Netherlands.
E-mail: c.vanweel@hag.umcn.nl
ADDRESS FOR CORRESPONDENCE
The Quality and Outcomes Framework:
too early for a final verdict
An editorial in this Journal in 2002
suggested that the new GP contract could
prove to be the requiem or renaissance for
general practice.1 What has been learned 5
years on?
One obvious impact of the Quality and
Outcomes Framework (QOF) has been the
high quality scores achieved in the first year
and the widely-publicised financial rewards.
In retrospect, it is easy to see how GPs were
able to score so well. Care was already
improving rapidly in the years leading up to
the new contract. So, for heart disease, for
example, the percentage of patients with
controlled blood pressure rose from 47% to
72% between 1998 and 2003, and the
percentage of patients with cholesterol
within recommended levels increased from
18 to 61% in the same period.2 The roots for
these improvements go back a decade or
more. Audit was introduced as a compulsory
part of the 1990 GP contract and seemed to
have a modest impact at the time.3,4 But
what happened during that decade was that
GPs gradually started using electronic
records, they got used to comparing their
care with others, and many GPs employed
nurses to improve the care of chronic illness.
So, when the QOF came along, much of the
infrastructure for quality improvement was
already in place, and GPs were able to
respond rapidly to the new incentives.
Since the QOF was introduced, quality of
care shows further improvement. For asthma
and diabetes, care is now improving more
rapidly than before the contract. For
coronary heart disease, where care was
already showing major change, the
improvement has continued at the same
rate.5 Care in relation to these three diseases
has undergone definite if modest
improvements over and above what was
already being achieved. These trends should
have some important impacts on health.6
Several commentators have doubted
whether the improvements so far represent
value for money in terms of £1 billion annual
investment, but what has been achieved is a
mechanism for an ongoing programme of
quality improvement in new areas that is
unique among national healthcare systems.
Mangin and Toop7 are unable to find
evidence for many of the indicators in the
QOF. This is hardly surprising. When a
rigorous process was used to develop
quality indicators for asthma, angina, and
diabetes, only a quarter of indicators that
GPs rated as ‘necessary to do and record’
were strongly evidence based.8 Quality
indicators are always going to contain a large
element of professional judgement, and that
should be applauded, not derided. What is
needed is a robust and transparent process
for incorporating professional judgement in
new indicators.
Any scheme which includes large financial
losses and gains is potentially open to
cheating. Cheating is hard to detect, but one
aspect of the QOF that still concerns
government is exception reporting. The
rationale for exception reporting is that
evidence-based guidelines were never
intended to apply to every patient who sits
down in front of his or her GP. Allowing the
GP to say: ‘This indicator doesn’t apply to
my patient’, makes it easier to align
managerial with professional incentives, and
to avoid inappropriate distortions of care. So
have GPs abused the ability to use
exception reporting? On the whole, they
have not. The median exception reporting
rate was 6% in the first year of the contract,9
and 5.3% in the second year.10 One practice
exception reported 86% of its patients in the
first year, but this top figure for exception
reporting has come down to 28% in the
second year. Primary care trusts obviously
have an inspection role for practices with
high rates of exception reporting, but
generally, there is little evidence of
widespread abuse. Other forms of gaming
are hard to detect. The suggestion that GPs
recoded patients to diagnoses other than
‘coronary heart disease’ in the run up to the
contract11 is cause for concern, although this
could be legitimate cleaning of disease
registers. However, it is a serious problem
that the current payment system
systematically penalises practices serving
deprived populations with high morbidity.12
The payment formula needs to encourage
casefinding in areas of high morbidity, not
discourage it.
It is often suggested that incentives will
widen health inequalities, because doctors
will concentrate on patients who are easier
to treat. When incentives were introduced for
cervical cytology and immunisation in 1990,
inequalities widened initially but over 6 or
7 years the gap narrowed so that there was
an overall halving of inequalities between
